Patient-reported outcomes and pharmacist actions in patients with multiple sclerosis managed by health-system specialty pharmacies.

Autumn D ZuckermanAimee M BanksJulie WawrzyniakElizabeth RightmierDana SimonsonAlicia L ZagelEvan TurcoAbbi BlevinsJosh DeClercqLeena Choi

Published in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (2023)

Patients on DMTs through an HSSP reported low rates of impacted productivity, relapse, and hospitalization due to MS, although patients with noncommercial insurance were more likely to have impacted productivity. Patients reporting impacted productivity and those taking certain DMTs may require more frequent pharmacist actions.

Keyphrases

patient reported outcomes
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
mass spectrometry
emergency department
adverse drug
drug induced